Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages' Radar
While HSBC maintains a 'buy' rating for Biocon it has cut its target price to Rs 390 from the earlier Rs 400 per share.
Siemens Energy India Ltd., Trent Ltd., and Biocon Ltd. were among the top companies on brokerages' radar on Thursday.
Siemens Energy India is set to make its debut, following its demerger from Siemens Ltd. in April 2025. As the company prepares for its listing, several brokerage firms have initiated coverage with optimistic target prices, highlighting the potential for investors.
While HSBC maintains a 'buy' rating for Biocon it has cut its target price to Rs 390 from the earlier Rs 400 per share.
NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out for on Thursday.
Brokerages On Siemens Energy
Antique
Antique initiated coverage on Siemens Energy with a 'buy' rating and a target price of Rs 3,179.
Siemens Energy is viewed as a strong play on advanced technology and scale.
The company is well-positioned to benefit from robust capex in the transmission and distribution sector.
Siemens Energy is also seen as a proxy for the decarbonisation theme in energy.
A solid order backlog of Rs 15,000 crore supports strong medium-term revenue visibility.
Antique expects the company to deliver an earnings CAGR of 35% over financial year 2024–2027.
Motilal Oswal
MOSL initiated a 'buy' on Siemens Energy with a target price of Rs 3,000.
The company has a long-standing presence in the transmission space and is expected to benefit from increased T&D investments.
Planned capital expenditure across facilities is likely to drive future financial growth.
The company is well-placed to tap into a strong addressable market in the T&D segment.
Revenue and profit are expected to grow at a CAGR of 25% and 31%, respectively, over financial year 2025–2027.
The brokerage expects Ebitda margins to expand to 21.4% by fiscal 2027.
HDFC Securities
HDFC Securities initiated a 'buy' with a target price of Rs 3,000, highlighting Siemens Energy as a play on decarbonisation.
The company’s T&D segment is expected to remain the dominant growth driver in the near to mid-term.
The high-voltage T&D market has expanded 2.5 times since pre-Covid levels.
Additional growth is expected from EPC solutions, turbines, and services.
A strong order backlog supports visibility and a projected profit CAGR of 30% over financial year 2025–2027.
HDFC Securities sees strong cash flows, low competitive intensity, and export opportunities as key strengths.
Brokerages On Trent
Morgan Stanley
Morgan Stanley maintains an 'outperform' rating with a target price of Rs 6,359.
While growth may be volatile, the company aspires to grow revenues 10 times.
Management highlighted strategies enabling long-term growth at a 25% CAGR, albeit with a bumpy path.
Trent is positioning itself as a multi-category business, supported by emerging segments.
The company will continue its micro-market strategy, which aligns with the brand’s positioning.
Management emphasised the critical role of the supply chain in supporting this growth.
Macquarie
Macquarie maintained an 'outperform' with a raised target price of Rs 7,000.
Expansion in store density may impact same-store sales growth, but long-term growth prospects remain strong.
Technology-led cost control measures are expected to maintain a healthy return profile.
Growth is to be driven by store expansion, entry into adjacent categories, and improved cost management.
While the private-brand strategy in Star grocery is promising, competition from quick commerce poses risks.
Supply chain tech investments are expected to strengthen the company’s competitive position in fashion retail.
Goldman Sachs On PNB Housing
Goldman Sachs maintained a 'buy', with a target price of Rs 1,223.
New profit pools are expected to support earnings visibility going forward.
Management aims to increase yields across segments to boost margins.
A favourable cost of funds trajectory will aid margin expansion.
Growth is likely to be driven by higher-yielding business segments.
PMAY 2.0 is seen as a key catalyst for accelerating growth in affordable housing.
HSBC On Biocon
HSBC maintained a 'buy' but reduced the target price to Rs 390 from Rs 400.
The company launched a QIP to address financial obligations, including payments to Goldman Sachs AIF.
A successful QIP is expected to ease the debt burden.
However, operational turnaround depends on scaling up newer biosimilars.
FDA approval and the US launch of insulin aspart is seen as a key catalyst.
Goldman Sachs On Aavas Financiers
Goldman Sachs maintained a 'buy' with a target price of Rs 2,277.
The outlook on both growth and profitability remains positive.
There are signs of recovery in rural India, supporting loan demand.
Revamped PMAY scheme is a tailwind for affordable housing finance.
Improving yields and favourable borrowing costs are expected to boost NIMs.
Asset quality and overall profitability remain robust.
Citi On Asian Paints
Citi maintained a 'sell' with a target price of Rs 2,100.
Value growth in financial year 2026 is expected to remain in low single digits.
Volume growth is likely to be 3–4%, compared to 6–7% in financial year 2025.
Increased trade incentives have been offered due to competitive pressures.
Despite this, Asian Paints continues to offer lower incentives versus peers.
Long-term volume growth target remains 9–10%.
Medium-term focus is on revenue stability and market share retention.
Dealer network is non-exclusive, with limited loyalty constraints.
New entrants have not yet gained meaningful traction among large dealers.
Citi On Page Industries
Citi maintained a 'sell' with a target price of Rs 37,200.
The demand environment continues to be subdued.
Fourth quarter performance benefitted from an earlier Eid, while first quarter is facing some geopolitical impact.
Inventory correction in channels is largely complete.
Primary sales are expected to align with secondary demand going forward.
Financial year 2026 will likely see higher employee and IT-related costs.
Margins are expected to remain within 19–21%, down from 21.5% in fiscal 2025.
Citi On Titan
Citi maintained a 'neutral' rating with a target price of Rs 3,800.
Competitive intensity in the jewellery segment has significantly increased.
The worst phase for the company appears to be over.
Tanishq has rationalised gold pricing and making charges over the last few years.
Titan continues to reinvest in scale and market leadership to sustain growth.
Current margin levels are expected to be stable.
The LGD impact is more visible in solitaire products.
M&A strategy will be guided by meaningful scale and relevance.
Citi On Pidilite
Citi maintained a 'sell', with a target price of Rs 2,800.
No major improvement is seen in the demand trend for B2C or the Consumer & Bazaar segment.
Early and unseasonal rains may affect certain categories.
Rural demand continues to outpace urban demand.
Margins can be sustained between 20–24% at current raw material prices without price hikes.
Risks include geopolitical tensions, weak consumer sentiment, and rising RM costs.
Tailwinds include stronger rural/urban demand and increased infrastructure and real estate activity.
Citi On Kalyan Jewellers
Citi maintained a 'buy' with a target price of Rs 650.
Demand trends remain healthy across markets.
The company plans to open 90 new stores in financial year 2026, including 6–7 overseas and 9–10 in South India.
The mix of studded jewellery is expected to stay stable.
Candere is projected to break even or post marginal profits in fiscal 2026.
The competitive landscape remains stable with no major price-based challenges.
Despite higher gold prices, ticket sizes have increased less than 10%.
Same-store growth is primarily driven by an increase in the number of buyers.
Kalyan plans to repay Rs 350 crore in debt during financial year 2026.
